Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 14Aldurazyme
02 1Aldurazyme Net Product Revenues Marketed by Sanofi
03 1Aldurazyme net product revenues marketed by Sanofi
04 1Aldurazyme net product revenues marketed by Sanofi Genzyme
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disorders
Currency : USD
2019 Revenue in Millions : 244
2018 Revenue in Millions : 225
Growth (%) : 9
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disorders
Currency : USD
2020 Revenue in Millions : 283
2019 Revenue in Millions : 271
Growth (%) : 4
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disorders
Currency : USD
2021 Revenue in Millions : 268
2020 Revenue in Millions : 255
Growth (%) : 4
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2022 Revenue in Millions : 293
2021 Revenue in Millions : 268
Growth (%) : 9
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 301
2022 Revenue in Millions : 293
Growth (%) : 4
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disease
Currency : USD
2014 Revenue in Millions : 8.20%
2013 Revenue in Millions :
Growth (%) :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disease
Currency : USD
2015 Revenue in Millions : 189
2014 Revenue in Millions : 215
Growth (%) : 14%
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2016 Revenue in Millions : 213
2015 Revenue in Millions : 207
Growth (%) : 3
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2017 Revenue in Millions : 257
2016 Revenue in Millions : 249
Growth (%) : 3
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2018 Revenue in Millions : 233
2017 Revenue in Millions : 234
Growth (%) : -0.50%
LOOKING FOR A SUPPLIER?